New Clinical Trial for Previously Untreated Patients

Joined: August 5th, 2013, 10:49 pm

May 18th, 2018, 1:51 am #1

I happened to notice a new clinical trial is open for previously untreated patients.  The facilities include Memorial Sloan Kettering in NYC; Dana Farber in Boston; and Yale Medical Center in New Haven, CT.  Here is a brief summary:   This is a multi-center, open label, single arm, phase II trial of the oral BRAF inhibitor, vemurafenib, plus obinutuzumab in patients with previously untreated HCL. Below is a link.  This doesn't apply to most of us since it is for new patients.  But, it might apply to someone who is newly diagnosed and looking for options.  

https://www.clinicaltrials.gov/ct2/show ... mia&rank=5
Quote
Like
Share

Joined: March 30th, 2003, 5:17 pm

May 18th, 2018, 2:05 am #2

Thanks for posting this. Someone may well benefit from the info.
Quote
Like
Share


Confirmation of reply: